Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 5R37CA248563-05 Asad Umar, D.V.M., Ph.D.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

The MW Cancer Prevention Clinical Trials Network 5UG1CA242635-05 Donald Johnsey
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation 5R01CA238423-05 Goli Samimi, Ph.D., M.P.H.
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 1R01CA279401-01A1 Rachel Altshuler, Ph.D.
Barton, Jennifer Kehlet

University Of Arizona
United States

Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers 5R01CA260399-04 Guillermo Marquez, Ph.D.
Basu, Partha

International Agency For Res On Cancer
United States

A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs 5R37CA275824-02 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Bedrosian, Isabelle

University Of Tx Md Anderson Can Ctr
United States

Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers 1UG3CA290454-01A1 Altaf Mohammed, Ph.D.
Beretta, Laura

University Of Tx Md Anderson Can Ctr
United States

Early Detection of Hepatocellular Carcinoma 5R01CA195524-09 Matthew Young, Ph.D.
Bergan, Raymond C.

University Of Nebraska Medical Center
United States

Regulation of extracellular proteases in prostate cancer progression to a metastatic phenotype 3R01CA276846-02S1 John Clifford, Ph.D.